Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

LQDA

Liquidia (LQDA)

Liquidia Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:LQDA
일자시간출처헤드라인심볼기업
2024/06/0510:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
2024/06/0510:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
2024/06/0320:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
2024/06/0320:00GlobeNewswire Inc.District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ LaunchNASDAQ:LQDALiquidia Corporation
2024/06/0106:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
2024/05/2921:00GlobeNewswire Inc.Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
2024/05/1505:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
2024/05/1406:43GlobeNewswire Inc.Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
2024/05/1406:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LQDALiquidia Corporation
2024/05/1021:00GlobeNewswire Inc.Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
2024/05/0721:30GlobeNewswire Inc.Liquidia Corporation to Present at BofA Securities Health Care Conference 2024NASDAQ:LQDALiquidia Corporation
2024/05/0721:00GlobeNewswire Inc.Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024NASDAQ:LQDALiquidia Corporation
2024/04/0222:00GlobeNewswire Inc.Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
2024/04/0119:00GlobeNewswire Inc.Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powderNASDAQ:LQDALiquidia Corporation
2024/03/1319:00GlobeNewswire Inc.Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
2024/03/0620:30GlobeNewswire Inc.Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024NASDAQ:LQDALiquidia Corporation
2024/03/0509:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
2024/01/3020:30GlobeNewswire Inc.Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual CongressNASDAQ:LQDALiquidia Corporation
2024/01/2521:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
2024/01/2520:00GlobeNewswire Inc.Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powderNASDAQ:LQDALiquidia Corporation
2024/01/2321:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
2024/01/1921:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
2024/01/1920:30GlobeNewswire Inc.Liquidia Corporation Announces Updates to Operations LeadershipNASDAQ:LQDALiquidia Corporation
2024/01/1707:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
2024/01/1707:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
2024/01/1707:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
2024/01/1621:42Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LQDALiquidia Corporation
2024/01/0906:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
2024/01/0822:22GlobeNewswire Inc.Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files CounterclaimsNASDAQ:LQDALiquidia Corporation
2024/01/0520:45GlobeNewswire Inc.Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
 검색 관련기사 보기:NASDAQ:LQDA